| Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor L Ma, T Dichwalkar, JYH Chang, B Cossette, D Garafola, AQ Zhang, ... Science 365 (6449), 162-168, 2019 | 316 | 2019 |
| Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy N Momin, NK Mehta, NR Bennett, L Ma, JR Palmeri, MM Chinn, EA Lutz, ... Science translational medicine 11 (498), eaaw2614, 2019 | 168 | 2019 |
| BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription Z Sheng, L Ma, JE Sun, LJ Zhu, MR Green Blood, The Journal of the American Society of Hematology 118 (10), 2840-2848, 2011 | 144 | 2011 |
| A therapeutically targetable mechanism of BCR-ABL–independent imatinib resistance in chronic myeloid leukemia L Ma, Y Shan, R Bai, L Xue, CA Eide, J Ou, LJ Zhu, L Hutchinson, J Cerny, ... Science translational medicine 6 (252), 252ra121-252ra121, 2014 | 138 | 2014 |
| STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity EL Dane, A Belessiotis-Richards, C Backlund, J Wang, K Hidaka, ... Nature Materials 21 (6), 710-720, 2022 | 117 | 2022 |
| Homologous recombination as an evolutionary force in the avian influenza A virus CQ He, ZX Xie, GZ Han, JB Dong, D Wang, JB Liu, LY Ma, XF Tang, ... Molecular biology and evolution 26 (1), 177-187, 2009 | 95 | 2009 |
| Identification of a natural multi-recombinant of Newcastle disease virus GZ Han, CQ He, NZ Ding, LY Ma Virology 371 (1), 54-60, 2008 | 75 | 2008 |
| Resistance to vemurafenib resulting from a novel mutation in the BRAFV 600 E kinase domain TR Wagenaar, L Ma, B Roscoe, SM Park, DN Bolon, MR Green Pigment cell & melanoma research 27 (1), 124-133, 2014 | 70 | 2014 |
| Homologous recombination is apparent in infectious bursal disease virus CQ He, LY Ma, D Wang, GR Li, NZ Ding Virology 384 (1), 51-58, 2009 | 62 | 2009 |
| CRISPR-Cas9–mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy L Ma, JI Boucher, J Paulsen, S Matuszewski, CA Eide, J Ou, G Eickelberg, ... Proceedings of the national academy of sciences 114 (44), 11751-11756, 2017 | 55 | 2017 |
| A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells CS Park, AH Lewis, TJ Chen, CS Bridges, Y Shen, K Suppipat, M Puppi, ... Blood, The Journal of the American Society of Hematology 134 (22), 1960-1972, 2019 | 41 | 2019 |
| GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2 ZF Yang, H Zhang, L Ma, C Peng, Y Chen, J Wang, MR Green, S Li, ... Proceedings of the National Academy of Sciences 110 (6), 2312-2317, 2013 | 33 | 2013 |
| Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity L Ma, A Hostetler, DM Morgan, L Maiorino, I Sulkaj, CA Whittaker, ... Cell 186 (15), 3148-3165. e20, 2023 | 20 | 2023 |
| Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cells L Ma, ML Pak, J Ou, J Yu, P St. Louis, Y Shan, L Hutchinson, S Li, ... Proceedings of the National Academy of Sciences 116 (21), 10482-10487, 2019 | 11 | 2019 |
| Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses LJ Dooling, JC Andrechak, BH Hayes, S Kadu, W Zhang, R Pan, ... Nature Biomedical Engineering 7 (9), 1081-1096, 2023 | 6 | 2023 |
| ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK. CAR-T cells E Bergaggio, WT Tai, A Aroldi, C Mecca, E Landoni, M Nüesch, I Mota, ... Cancer cell 41 (12), 2100-2116. e10, 2023 | 5 | 2023 |
| Eradication of tumors with pre-existing antigenic heterogeneity by vaccine-mediated co-engagement of CAR T and endogenous T-cells L Ma, DM Morgan, I Sulkaj, P Yousefpour, CA Whittaker, W Abraham, N Li, ... bioRxiv, 2022.10. 05.511036, 2022 | 5 | 2022 |
| Cooperative phagocytosis underlies macrophage immunotherapy of solid tumours and initiates a broad anti-tumour IgG response JC Andrechak, LJ Dooling, BH Hayes, S Kadu, W Zhang, R Pan, ... biorxiv, 2022.01. 01.474150, 2022 | 4 | 2022 |
| High-throughput screening of tyrosine kinase inhibitor resistant genes in CML L Ma, J Roderick, MA Kelliher, MR Green Chronic Myeloid Leukemia: Methods and Protocols, 159-173, 2016 | 4 | 2016 |
| Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof DJ Irvine, L Ma US Patent App. 17/257,671, 2022 | 2 | 2022 |
